Molecular-genetic portrait of virulence of Stenotrophomonas maltophilia

Cover Page


Cite item

Abstract

Introduction. Stenotrophomonas maltophilia is an opportunistic pathogen that is intrinsically resistant to a wide range of antibiotics. The bacterium is associated with a number of serious diseases and makes a significant contribution to the pathogenesis of polymicrobial infections. S. maltophilia has a wide range of virulence factors, information about which is currently presented in the form of scattered and unconsolidated data.

Purposes and objectives: critically analyze and summarize current data regarding the molecular-genetic aspects of S. maltophilia virulence for better understanding of the pathogenesis of infections associated with this pathogen.

Materials and methods. An analysis of information from 80 modern literary sources devoted to the study of the virulent properties of S. maltophilia at the molecular-genetic level has been carried out. The analysis focuses on the mechanisms of production of virulence factors and their genetic determinants.

Results.The molecular mechanisms of virulence that determine the infectious process caused by S. maltophilia have been analyzed and summarized, including the adhesive function of the surface structures of the bacterial cell (lipopolysaccharides, pili/fimbriae, flagella), the production of extracellular enzymes, the ability to form biofilms on abiotic surfaces and on the tissues of the macroorganism, the functioning of efflux pumps, secretion of small molecules into the external environment by the intercellular information exchange system Quorum Sensing, as well as the influence of iron metabolism on the virulence properties of S. maltophilia.

Conclusion. The adaptation mechanisms that allow S. maltophilia to adapt to new habitat niches and survive in the human body and unfavorable environmental conditions have been poorly studied. An analytical review summarizing current information on the molecular-genetic aspects of S. maltophilia virulence will be of interest to clinicians and researchers studying the fundamental mechanisms of virulence.

Full Text

Introduction

Stenotrophomonas maltophilia is a gram-negative microorganism that is widespread in nature and is often isolated from water sources, soil, and plant and animal samples [1]. According to the Bergey's Manual1, the genus Stenotrophomonas includes three species. Modern alternative taxonomic resources attribute to this genus at least 19 species, which demonstrate a wide variety of metabolic pathways, as well as genetic and phenotypic heterogeneity both within the genus and between strains of each individual species [2–4].

S.  maltophilia is well adapted to exist in a variety of habitats, including environments with a low content of nutrient substrates, is capable of utilizing a wide range of carbon sources (including trichlorethylene, gasoline, chloroform), and is naturally resistant to salts of heavy metals [5, 6].

S.  maltophilia is an opportunistic agent that is intrinsically multidrug resistant to a wide range of antibiotics. The microorganism is associated with a number of serious diseases and is isolated in respiratory and urological infections, bacteremia, endocarditis, etc. [7]. The bacterium is also of interest as an active member of polymicrobial bacterial communities, which affects the metabolism of surrounding microorganisms, including through antagonistic suppression of representatives of other species (interspecific antagonism). A notable example of such a community is observed in cystic fibrosis, where S. maltophilia colonizes the respiratory tract of patients and often coexists with Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus influenzae, Burkholderia cenocepacia, nontuberculous mycobacteria, etc. [8, 9].

The pathogenetic basis of the bacterium is determined by virulence factors — molecular structures that ensure the development of the infectious process. S. maltophilia has a fairly wide range of virulence factors (or factors potentially associated with virulence), which include the surface structures of the bacterial cell (lipopolysaccharides (LPS), pili/fimbriae and flagella, the production of extracellular enzymes (in particular, proteases, elastases, lipases, DNases and RNases, fibrinolysin), the ability to form biofilms on abiotic surfaces and on tissues of the macroorganism and secrete small molecules into the external environment through QS (quorum sensing) systems called “diffusible signal factor” — DSF) [6, 11].

Adhesins as a virulence factor

The key stage of the initial microorganism-host interaction is adhesion, i.e. the attachment of a bacterium to the cells of the macroorganism's tissue. Already at the adhesion phase, bacteria initiate their own biochemical processes aimed at proliferation, invasion, secretion of toxins and activation of response signaling cascades of host cells.

Bacterial adhesion factors (adhesins) are represented by proteins and LPS. Protein adhesins are divided into fimbrial and afimbrial. Lipopolysaccharide and polysaccharide adhesins are associated with the cell membrane (cell wall, outer membrane and capsule). It should be noted that the functions of LPS in pathogenesis are not limited to the primary “bacterium-macroorganism” interaction: their significant role remains at subsequent stages of the infectious process.

LPS (endotoxin) of S. maltophilia consists of lipid A, core oligosaccharide, and O-antigen (O-polysaccharide) [12, 13]. Lipid A in LPS is a potential inducer of tumor necrosis factor alpha (TNF-α) production by macrophages, as demonstrated by V.J. Waters et al. in a mouse model [14]. Despite the relatively low invasiveness of S. maltophilia, the level of TNF-α after stimulation of the RAW macrophage cell line with purified lipid A of S. maltophilia was significantly higher than the level obtained when stimulated with lipid A isolated from the reference strain P. aeruginosa PAO1 [14]. Core oligosaccharides play an important role in the formation of LPS structure and, consequently, virulence. It has been established for many microorganisms that defective forms of core oligosaccharides lead to a significant decrease in virulence or the emergence of avirulent strains, for example, P. aeruginosa [15] and Bordetella bronchiseptica [16]. An equally important contribution to the formation of virulence is made by O-antigens, the complete loss of which or the presence of defects in their structure due to impaired biosynthesis can reduce virulence of the microorganism, which has been demonstrated, in particular, in species Burkholderia pseudomallei [17], P. aeruginosa [15], Brucella abortus [18]. LPS from different S. maltophilia strains are highly heterogeneous: at least 31 O-antigen variants are known [19].

A number of genes are involved in the processes of sugar metabolism and their incorporation into LPS in S. maltophilia. The spgM gene, encoding the bifunctional enzyme phosphoglucomutase/phosphomannomutase, is similar to the algC gene responsible for the synthesis of alginate in P. aeruginosa [13, 20]. Two operons play an important role in the biosynthesis of O-antigen: rmlBACD and xanAB. T.P. Huang et al., having performed SDS-PAGE analysis of purified LPS from S. maltophilia strains with mutations in the rmlA, rmlC and xanB genes, found that these genes are directly involved in the control of O-antigen biosynthesis, and the xanB gene is also involved in the synthesis of the core component of LPS [21]. The authors showed that both operons also influence the synthesis of exopolysaccharides produced by S. maltophilia, which are key components of biofilms.

In addition to surface LPS, flagella are involved in the adhesion stage. S. maltophilia has from one to several flagella located at the pole(s) of the bacterial cell, which, in particular, contribute to the primary attachment to the cells of the tracheal mucosa of mice and induce a specific immune response of the macroorganism [22, 23]. When BALB/c mice were infected with purified flagellin S. maltophilia, an increased level of cytokines was recorded in the animals after 4 hours: interleukins (IL)-1β, -10 and TNF-α. The number of neutrophils, leukocytes and monocytes also increased, which increased nonspecific protection of mice against both S. maltophilia and Staphylococcus aureus [24].

А. Pompilio et al. compared the severity of the disease in mice after aerosol infection with a wild strain of S. maltophilia SM111 and a mutant variant (ΔfliI) lacking flagella. The authors found no statistically significant differences in animal weight loss, lung tissue damage, or mortality rates, although TNF-α values were higher in animals infected with the wild strain. Finally, the authors made a peculiar assumption that the presence of flagella (and therefore motility) may not be associated with the virulent properties of S. maltophilia in the pathogenesis of lung diseases [25]. It is hypothetically possible that during a chronic infection, a microorganism lacking such a significant immunogenic factor as flagellin will have advantages by reducing the host’s immune response from patients with cystic fibrosis, which, in particular, was observed in non-flagella-producing strains of P. aeruginosa [26]. However, most studies indicate a positive correlation between motility and primary adhesion, e.g. [22, 23, 27]. Apparently, the above-mentioned assumption about the absence of a relation between the presence of flagella and the virulent properties of S. maltophilia can only apply to later, chronic stages of infection, when the stages of adhesion of the microorganism preceding the disease have already been completed.

The motility of S. maltophilia and the level of flagellin expression depend on environmental factors and are controlled by a complex and incompletely understood genetic system. It has long been established that cyclic diguanosine monophosphate (c-di-GMP), an important signaling molecule (second messenger) that controls the physiology of the microorganism, its motility and the process of biofilm formation, is involved in the regulation of expression [28]. High c-di-GMP concentration in the cell is associated with decreased motility [29].

The intracellular concentration of c-di-GMP is regulated by changes in the activity of two classes of enzymes: diguanylate cyclases and phosphodiesterases. The former synthesize c-di-GMP from 2 molecules of guanosine triphosphate, and phosphodiesterases hydrolyze c-di-GMP to linear diguanosine monophosphate or guanosine monophosphate (GMP) [30–32].

For a number of microorganisms, some genetic determinants are known, the so-called master regulators and their homologues, which initiate and regulate the expression of flagellin genes, for example, FlrA (FleQ) in P. aeruginosa and Vibrio cholera, flaK and flaM in Vibrio parahaemolyticus [33–36]. For S. maltophilia, the mechanisms by which c-di-GMP controls the synthesis and number of flagella remain poorly understood, and only a few studies are devoted to the fundamental aspects of their functioning.

In 2014, J. Yang et al. found that the regulation of the expression of flagellar genes in S. maltophilia is carried out by the master regulator FleQ (Smlt2295) homologous with P. aeruginosa [37]. This transcription factor (enhancer-binding protein), acting in complex with the putative ATPase FleN, is inhibited by binding to c-di-GMP, which in turn leads to a decrease in flagellar gene expression and promotes the initiation of biofilm formation. In the absence of c-di-GMP, i.e. in the unbound state, the situation is reversed: FleQ promotes increased expression of flagellins and, accordingly, reduces the ability to “sedentary” way of vital activity in biofilms.

W. Liu et al. have demonstrated a correlation between increased expression of the BsmR gene (regulatory protein, phosphodiesterase with an EAL-binding domain) and increased motility, as well as decreased aggregation ability in the S. maltophilia strain CGMCC 1.1788 [38]. Thus, BsmR acts as a negative regulator of biofilm formation. The BsmR operon controls the expression of at least 349 genes, 34 of which are involved in flagellin synthesis under the positive regulation of the transcription factor FsnR, which initiates transcription by binding to the promoter regions of two operons: Smlt2303 and Smlt2318 [39, 40].

In 2022, X. Zhang et al. analyzed genes potentially affecting c-di-GMP levels in S. maltophilia, namely those encoding proteins containing the GGDEF, EAL and HD-GYP domains [41]. The authors found 33 genes with the desired sequences in the genome of the microorganism and constructed mutant strains with inactivated genes. 13 out of the 33 mutant strains had reduced motility, indicating the potential role of the corresponding genes in its regulation. In addition, as a result of the analysis of diguanylate cyclases and phosphodiesterases, the authors identified a new Fe2+-dependent phosphodiesterase SisP, which, with an increase in the concentration of iron cations, increased its enzymatic activity in direct proportion, i.e. hydrolyzed c-di-GMP in a dose-dependent manner.

Type 1 fimbriae (SMF-1) play the role of adhesins, ensuring the attachment of S. maltophilia to epithelial cells. In particular, adhesion to biotic and abiotic surfaces has been shown to be inhibited in the presence of anti-SMF-1 antibodies [42]. Fimbriae are also involved in haemagglutination and biofilm formation and [42] the administration of fimbrin to BALB/c mice stimulated the production of IL-1β, TNF-α and an increase in phagocyte activity in them [43]. It should be noted that, in contrast to clinical isolates, S. maltophilia strains isolated from the environment lacked such fimbriae [44], which suggests their significant role in adhesion/colonization of the respiratory tract in patients with cystic fibrosis. The production of fimbriae in S. maltophilia is controlled by the operon Smlt0706Smlt0709 [45]. Although the amino acid sequences of fimbrin in S. maltophilia are similar to those of pathogenic E. coli strains, the N-terminal region of the SMF-1 protein in S. maltophilia differs significantly from other bacterial families (50–61% agreement), which suggests a fairly strong phylogenetic distance of this species [42].

Type IV pili also play an important role in the adhesion of S. maltophilia to biotic and abiotic surfaces, including the biofilm formation [46]. Despite the fact that type IV pili are considered by many authors as an important virulence factor, no significant correlations between virulence and the presence of the pil gene family associated with pili formation were found in S. maltophilia. The phenomenon of the formation of more massive biofilms in strains with increased motility was described by A. Pompilio et al., but this phenomenon was observed in a small sample of strains isolated from sputum samples of patients with cystic fibrosis [5]. Of the 9 strains studied that were not motile, only 2 did not form biofilms. The authors concluded that motility was not a necessary factor influencing the ability to form biofilms. At the same time, S. maltophilia strains isolated from other diseases had an increased ability to form biofilms in comparison with isolates from patients with cystic fibrosis. Obviously, it should be clarified here that many authors mean by motility both “swimming activity” and “twitching” of the bacterial cell.

Secretion systems and extracellular enzymes

Clinical strains of S. maltophilia produce siderophores, proteases (StmPr1-4), lipases (including phospholipases C and D), nucleases, gelatinase, elastase, fibrolysin/streptokinase, esterases, hyaluronidases, hemolysin and cytotoxins, which act as virulence factors and promote colonization and persistence of the microorganism, participating in adhesion, damage and destruction of host cells, capture of iron ions necessary for bacterial reproduction [47, 48].

Based on genome sequencing data, of the 9 known bacterial secretion systems, systems of types I, II, IV, V and VI were found in S. maltophilia [45, 49, 50]. While the role of secretion systems in the formation of virulence is well known for many microorganisms, it was described in sufficient detail for S. maltophilia only for systems of types II (Xps type II) and IV.

The clinical strain of S. maltophilia K279a has a T2SS system (gsp and xps genes), through which at least 7 proteins are secreted, including three serine proteases StmPr1-3, which cause a cytotoxic effect in lung epithelial cells, degradation of fibronectin, fibrinogen and IL-8 [51, 52]. The StmPr4 protease produced by S. maltophilia is also known, but its functional role has not been clarified yet [53, 54].

S. maltophilia produces 13 potential antibacterial effector proteins. At the same time, the nucleotide sequences encoding them are highly conserved for different strains of S. maltophilia [55]. These effectors are produced by the type IV secretion system (T4SS), which is found in both strains isolated from natural sources and clinical isolates of S. maltophilia [56]. This system, called VirB/D4 T4SS, is similar to T4SS in bacteria of the closest genus, Xanthomonas, and is encoded by the chromosomal genes virB1-virB11 and virD4. Effector proteins are secreted by the T4SS system into the environment or by direct contact immediately into a competing bacterial cell, thereby realizing interspecific antagonism.

The interspecific antagonism inherent in S. maltophilia was elegantly described by M.Y. Nas et al. [56]. The authors showed that S. maltophilia strains, using T4SS, caused the death of the natural isolate of P. aeruginosa 7700, P. aeruginosa PAO1 and P. aeruginosa PAK strains. Interestingly, S. maltophilia also affects some other species of the genus Pseudomonas, but very selectively. For example, S. maltophilia kills P. mendocina, but not P. fluorescens, P. putida or P. stutzeri.

It is noteworthy that from the above-mentioned 13 antibacterial effectors of S. maltophilia, two potential proteins were isolated — RS14245 and RS14255, which have bactericidal properties against representatives of the genera Pseudomonas and Escherichia. The effectors RS14245 and RS14255, neutralized using blocking proteins, when added to the medium, did not lead to the death of laboratory and clinical strains of P. aeruginosa and E. coli. Mutant strains lacking these proteins or the T4SS system had significantly reduced bactericidal properties [55].

The data obtained are interesting from various points of view. On the one hand, the secretion of effectors that suppress other bacterial species is a significant factor that increases the virulence of S. maltophilia; on the other hand, the isolation and study of such effectors can potentially be used to create new antimicrobial therapeutics for targeted therapy of infections caused by Pseudomonas and Escherichia.

It should be noted that the T4SS system is used by S. maltophilia not only for competitive interspecific inhibition. The products of this system also perform other important functions — they inhibit the apoptosis in host epithelial cells and initiate it in macrophages [56].

Biofilms

During the biofilm formation, the primary adhesion (weak reversible attachment) of planktonic counterparts of S. maltophilia occurs within 30–60 minutes. The second stage develops after 4 hours, at which the microorganism is firmly attached to the surface with the participation of semi-flexible fimbriae, flagella filaments and surface LPS. The attached cells begin to produce exopolysaccharides, forming the extracellular matrix, and after approximately 10 hours they form the first surface microcolonies. After 18–24 hours, the process enters the third stage, at which cell differentiation occurs in the maturing biofilms, microchannels are formed for the transport of water, salts, nutrients and the exchange of communication signaling molecules (QS), which will be discussed below. At the last stage, mature biofilms gradually “bud off” planktonic counterparts of bacteria, which, due to their inherent motility, begin to spread and colonize new niches [20].

In 2020, L. Ramos-Hegazy et al., having analyzed the library of mutant transposons they had created, identified the GpmA gene encoding phosphoglycerate mutase, a glycolytic enzyme potentially involved in the initial stages of biofilm formation both on polystyrene and on human bronchial epithelial cell lines [57]. S. maltophilia strains with the knocked out GpmA gene had a significantly reduced rate of biofilm formation in the first hours compared to the wild-type strain. Interestingly, after 6 hours, the difference in the rate of biofilm formation in the wild and mutant strains was completely leveled, which suggests the participation of the GpmA gene as a mediator at the initial stages of adhesion and biofilm formation [57, 58].

A. Pompilio et al. analyzed 85 strains isolated from both cystic fibrosis patients and other infections. The vast majority of all strains (88.2%) formed biofilms in the plate test. At the same time, strains associated with cystic fibrosis demonstrated lower optical density of biofilms, but had greater multiple resistance in comparison with “non-cystic fibrosis” strains [59]. It is likely that enhanced biofilm formation may serve as a protective survival mechanism specifically for susceptible microorganisms.

The analysis of transcriptomic profiles of cells from biofilms (in comparison with planktonic counterparts) showed that only a relatively small proportion of genes are involved in the transition to existence in biofilms: the expression level decreases in 1–3% of genes and increases in 6–9% of genes [60]. Nevertheless, the analysis of the available information on the role of numerous virulence factors leads to the conclusion that the transition of cells from the planktonic lifestyle to the “sedentary” one in biofilms is initiated by many mechanisms that require further study.

Efflux pumps as virulence factors

As a rule, the efflux pumps are considered to be among the mechanisms that provide microorganisms with resistance to antimicrobial therapeutics. In the meantime, the functions of some types of efflux pumps are broader — they go beyond the scope defined by the term “antibiotic bacterial resistance” and are involved in the molecular mechanisms of the formation of virulence properties.

The efflux pumps contribute significantly to the natural resistance of S. maltophilia to antimicrobial therapeutics. Pumps of various types found in bacteria remove a wide range of therapeutics: fluoroquinolones, tetracycline and doxorubicin under the control of the SmrA pump; aminoglycosides, macrolides and polymyxins — through the MacABCsm pump belonging to the same family of ABC (from ATP-binding cassette) pumps [61].

The EmrCABsm pump from the MFS (major facilitator superfamily) transporter superfamily is responsible for the removal of nalidixic acid, erythromycin, carbonyl cyanide-3-chlorophenylhydrazone and tetrachlorosalicylanilide) [62]. FusA (ABC type) removes fusaric acid [63]. In addition, S. maltophilia has 8 types of RND-type pumps (Sme*), for 7 of which (except SmeMN) their role in the formation of antibiotic bacterial resistance has already been established. In addition to the antimicrobial therapeutics listed above, they are also involved in the transport of sulfamethoxazole, chloramphenicol, trimethoprim and trimethoprim-sulfamethoxazole [64].

It is interesting to note that, besides the known (and currently considered the main) function of removing xenobiotics from the bacterial cell, the efflux pumps SmeYZ and MacABCsm also influence the formation of flagella, the motility of S. maltophilia and the formation of biofilms. At the same time, MacABCsm differs from homologous pumps of other microorganisms. In particular, the expression of its operon is constitutive, of an “innate” nature, and the pump has its own original outer membrane protein MacCsm. In addition, in comparison with the homologous MacAB-TolC pump from E. coli, it has, as already noted, an expanded spectrum of excreted anitibiotics, including macrolides, aminoglycosides and polymyxins [61].

Another noteworthy function of the efflux pumps was described by C.J. Wu et al., who showed that the SmeYZ, SmeDEF and SbiAB pumps influenced the secretion of the siderophore stenobactin and the utilization of iron ions [65].

For some microorganisms, the role of the efflux pumps, in particular, their outer membrane structures — porins, in increasing the invasive properties of bacteria [66] and protecting the latter from phagocytosis [67], has been demonstrated, but such information has not been published for S. maltophilia.

Newly obtained data indicate that our current understanding of the main function of the efflux pumps, which is limited only to the removal of xenobiotics from the cell, is not an absolute dogma and requires critical revision and further study.

Relationship between virulence factors and iron availability

Iron is a vital element for the normal metabolism of non-glucose-fermenting gram-negative bacteria, including S. maltophilia. Competition for iron between bacteria and the host cells in chronic infections can negatively affect the host cells. The capture of iron by bacteria can be accompanied by both local tissue damage and systemic damage, for example, severe anemia. Therefore, systems that ensure the capture and transport of iron into the bacterial cell are considered to be significant virulence factors [68].

Siderophore- and heme-mediated transport systems of iron ions into the bacterial cell were found in S. maltophilia. The entAFDBEC operon encodes the synthesis of the siderophore enterobactin, which belongs to the class of catecholamines, binding and transporting Fe3+ into the bacterial cell. The heme-mediated system is under the control of the hgbBC and probably hmuRSTUV operons [69].

It is very interesting that the iron capture system is not only a virulence factor itself, but can also induce the activity of other mechanisms responsible for virulence properties. This occurs when there is a deficiency of iron in the environment. For example, the microorganism becomes more virulent in lung tissue in the presence of human iron-binding proteins (transferrin, lactoferrin) in the microenvironment, which reduce the level of free iron in the environment [70, 71]. In particular, under iron deficiency, the reference strain S. maltophilia K279a produced an increased amount of exopolysaccharides, DSF signaling molecules and formed thicker and more massive biofilms [69, 71]. It has been established that the iron supply system Fur and the transcriptional regulator σ-factor are involved in the regulation of this metabolic change, and the microorganism’s response to oxidative stress and the secretion of extracellular enzymes potentially depend on the bioavailability of iron [69, 71].

System Quorum Sensing

Like most gram-negative bacteria, S. maltophilia (in particular, reference strain K279a) has a QS system — unique signaling mechanism for intercellular bacterial information exchange [72]. The system is in charge of the production of extracellular signaling molecules called autoinducers, their detection and response (changes in the expression of certain genes) to the emergence of signaling molecules in the environment. Autoinducers accumulate in the environment, and when a certain threshold concentration is reached, the surrounding bacterial cells are able to detect them. Through this exchange of signaling molecules, cells regulate their metabolic mechanisms responsible for colonization and virulence, including changes in motility, biofilm formation, production of extracellular effectors and resistance properties [73, 74].

T.P. Huang et al. found that the main molecule in the QS system of S. maltophilia is the autoinducer DSF, which is cis-Δ2-11-methyl-lauric acid, a monobasic saturated fatty acid, the synthesis of which is regulated by the rpfF and rpfB (from regulation of pathogenicity factors) genes [72]. The rpf gene cluster, a regulator of virulence factors, is responsible for the synthesis of own DSF and recognition of “foreign” signaling molecules, for which two variants are known: rpf1 and rpf2, dividing the entire population of S. maltophilia into pheno- and genotypically different subpopulations [74]. The rpf cluster encodes the synthesis of RpfF synthase and the two-component RpfC/RpfG system, which are responsible for the detection and transduction of DSF. In its active form, RpfG phosphodiesterase hydrolyzes c-di-GMP to linear GMP, thereby regulating the expression of a number of virulence genes [75]. It should be noted here that only strains with the rpf-1 gene variant are initially able to produce DSF in detectable quantities without an external stimulus and, therefore, control the biofilm formation, as well as the motility and virulence of surrounding bacteria [74, 76]. In strains with rpf-2, the N-terminal (sensory) end of RpfF synthase is shortened. It is assumed that such strains with a reduced sensor domain require preliminary activation from the outside (for example, under the influence of DSF from other bacteria or from S. maltophilia strains with the rpf-1 system) to produce their own signaling molecules (DSF) into the environment [76].

It is interesting to note that strains carrying the rpf-2 gene variant (particularly genogroups C) exhibited greater levels of resistance to colistin and increased virulence against Galleria mellonella wax moth larvae, which are used as one of the models for assessing virulence. Apparently, this is due to the increased ability of rpf-2 strains to form biofilms [77]. At the same time, another model for determining virulence, which uses the Caenorhabditis elegans nematode, did not reveal such an association [77]. Genotyping and identification of the rpf variant are useful and important tools for epidemiological monitoring, which should take into account that S. maltophilia strains can potentially exchange rpf clusters through recombination during horizontal transfer of genes [76].

It has been fond that S. maltophilia has a two-component signal transduction system called BfmA–BfmK (Smlt4209–Smlt4208). The BfmA transcription factor included in the system binds to the bfmAbfmK promoter region and Smlt0800 (acoT), a gene encoding acyl-coenzyme A thioesterase, which is associated with biofilm formation [40].

Unlike P. aeruginosa, no full-fledged canonical LuxI/LuxR QS system based on signaling molecules of acyl-homoserine lactones has been found in S. maltophilia. However, R. Martínez et al., having performed a comparative analysis of genomes, showed that S. maltophilia has a gene Smlt1839, similar to the LuxR regulator, encoding the SmoR regulator (Stenotrophomonas maltophilia orphan regulator), which in vitro bound the synthetic lactone oxo-C8- HSL, a natural analogue of which is synthesized by P. aeruginosa. The addition of pooled supernatant of the medium on which P. aeruginosa, which produces lactones, was cultivated, gave an impetus to increased motility of S. maltophilia on Petri dishes [78]. In other words, despite the absence of the canonical LuxI/LuxR system, its own homologous intercellular exchange systems allow S. maltophilia to recognize QS-signaling molecules of other species with the LuxI/LuxR system. It is hypothetically possible that these systems are associated with the T4SS and, under certain conditions, can initiate the secretion of effectors aimed at inhibiting the growth of competitors (see above).

When considering the DSF system in S. maltophilia, it is worth mentioning the phenomenon of secretion through outer membrane vesicles [79]. Vesicles are small nanostructures secreted by bacteria that are capable of transporting nucleic acids, proteins and other small molecules, such as β-lactamases. S. Devos et al. found that the secretion of these vesicles was dramatically increased by S. maltophilia in the presence of imipenem [80]. The composition of the detected molecules carried in them is also interesting: these were two types of beta-lactamases encoded by chromosomes, outer membrane proteins and flagellins Smlt0387 and Smlt0184. These flagellins are homologues of Ax21, a protein that influences motility and biofilm formation in Xanthomonas oryzae. The functional role of this protein for S. maltophilia has not been established yet, but it is assumed that its secretion is initiated by DSF. The system of secretion through vesicles is classified as a potential virulence factor based on data that it affects the motility and biofilm formation of X. oryzae [81].

Conclusion

In the last decade, close attention has been paid to the study of the mechanisms of virulence of S. maltophilia. The natural multidrug resistance of the microorganism, its rapid adaptation to unfavorable environmental conditions and to new habitat niches, the graceful switching of metabolic processes by the bacterium — all this is of considerable interest both to specialists studying the fundamental mechanisms of virulence and to clinical researchers.

When discussing the virulent properties of S. maltophilia, it is necessary to take into account that this bacterium is characterized by pronounced intraspecific variability: strains isolated in one hospital and even from one patient can belong to fairly distant phylogenetic groups and have different phenotypes [4]. The rapid accumulation of adaptive mutations arising under the influence of the selective pressure of hospital conditions or the host cells, and horizontal transfer of genes are considered as probable reasons for such heterogeneity. Understanding the molecular processes that ensure rapid adaptation and, accordingly, survival of the microorganism in unfavorable conditions, will allow detecting potential targets for the development of new antibacterial therapeutics, as well as better understanding interspecific interactions in polymicrobial infections and establishing mechanisms of switching metabolic pathways during the transition of opportunistic pathogens from “natural” lifestyle to infectious intervention.

In this review, we have briefly presented current data on the molecular aspects of S. maltophilia virulence factors, without addressing the mechanisms of antibiotic bacterial resistance for the sake of brevity. We hope that the review article will be of interest to molecular biologists, clinical microbiologists and biochemists.

 

1 Palleroni N.J. Stenotrophomonas // Bergey’s Manual of Systematic of Archaea and Bacteria. URL: https://onlinelibrary.wiley.com/doi/10.1002/9781118960608.gbm01237

×

About the authors

Vladimir M. Mikhailovich

Engelhardt Institute of Molecular Biology

Email: nizarnn@yandex.ru
ORCID iD: 0000-0003-4894-1304

D. Sci. (Biol.), senior researcher, Deputy Head, Laboratory of biological microchips, Engelhardt Institute of Molecular Biology

Russian Federation, Moscow

Rustam N. Geydarov

Engelhardt Institute of Molecular Biology

Email: nizarnn@yandex.ru
ORCID iD: 0000-0002-4971-2629

senior laboratory assistant, Laboratory of biological microchips, Engelhardt Institute of Molecular Biology

Russian Federation, Moscow

Julia A. Bocharova

Pirogov Russian National Research Medical University

Email: nizarnn@yandex.ru
ORCID iD: 0000-0003-0197-0255

Cand. Sci. (Med.), senior researcher, Laboratory of molecular microbiology, Pirogov Russian National Research Medical University

Russian Federation, Moscow

Igor V. Chebotar

Pirogov Russian National Research Medical University

Author for correspondence.
Email: nizarnn@yandex.ru
ORCID iD: 0000-0002-6691-2171

D. Sci. (Med.), Head, Laboratory of molecular microbiology, Pirogov Russian National Research Medical University

Russian Federation, Moscow

References

  1. Gröschel M.I., Meehan C.J., Barilar I., et al. The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia. Nat. Commun. 2020;11(1): 2044. DOI: https://doi.org/10.1038/s41467-020-15123-0
  2. Ryan R.P., Monchy S., Cardinale M., et al. The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat. Rev. Microbiol. 2009;7(7):514–25. DOI: https://doi.org/10.1038/nrmicro2163
  3. Turrientes M.C., Baquero M.R., Sánchez M.B., et al. Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations. Appl. Environ. Microbiol. 2010;76(6):1746–58. DOI: https://doi.org/10.1128/AEM.02817-09
  4. Pompilio A., Crocetta V., Ghosh D., et al. Stenotrophomonas maltophilia phenotypic and genotypic diversity during a 10-year colonization in the lungs of a cystic fibrosis patient. Front. Microbiol. 2016;7:1551. DOI: https://doi.org/10.3389/fmicb.2016.01551
  5. Pompilio A., Pomponio S., Crocetta V., et al. Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: Genome diversity, biofilm formation, and virulence. BMC Microbiol. 2011;11:159. DOI: https://doi.org/10.1186/1471-2180-11-159
  6. Trifonova A., Strateva T. Stenotrophomonas maltophilia — a low-grade pathogen with numerous virulence factors. Infect. Dis. (Lond.). 2019;51(3):168–78. DOI: https://doi.org/10.1080/23744235.2018.1531145
  7. Brooke J.S. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin. Microbiol. Rev. 2012;25(1):2–41. DOI: https://doi.org/10.1128/CMR.00019-11
  8. Goss C.H., Mayer-Hamblett N., Aitken M.L., et al. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax. 2004;59(11):955–9. DOI: https://doi.org/10.1136/thx.2003.017707
  9. Coutinho H., Falcão-Silva V.S., Gonçalves G. Pulmonary bacterial pathogens in cystic fibrosis patients and antibiotic therapy: a tool for the health workers. Int. Arch. Med. 2008;1(1):24. DOI: https://doi.org/10.1186/1755-7682-1-24
  10. Looney W.J. Role of Stenotrophomonas maltophilia in hospital-acquired infection. Br. J. Biomed. Sci. 2005;62(3):145–54. DOI: https://doi.org/10.1080/09674845.2005.11732702
  11. Brooke J. Advances in the microbiology of Stenotrophomonas maltophilia. Clin. Microbiol. Rev. 2021;34(3):e0003019. DOI: https://doi.org/10.1128/cmr.00030-19
  12. Neal D.J., Wilkinson S.G. Lipopolysaccharides from Pseudomonas maltophilia structural studies of the side‐chain, core, and lipid‐a regions of the lipopolysaccharide from strain NCTC 10257. Eur. J. Biochem. 1982;128(1):143–9. DOI: https://doi.org/10.1111/j.1432-1033.1982.tb06944.x
  13. McKay G.A., Woods D.E., MacDonald K.L., Poole K. Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infect. Immun. 2003;71(6):3068–75. DOI: https://doi.org/10.1128/IAI.71.6.3068-3075.2003
  14. Waters V.J., Gómez M.I., Soong G., et al. Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia. Infect. Immun. 2007;75(4):1698–703. DOI: https://doi.org/10.1128/IAI.01469-06
  15. Goldberg J.B., Coyne M.J., Neely A.N., Holder I.A. Avirulence of a Pseudomonas aeruginosa algC mutant in a burned-mouse model of infection. Infect. Immun. 1995;63(10):4166–9. DOI: https://doi.org/10.1128/iai.63.10.4166-4169.1995
  16. West N.P., Jungnitz H., Fitter J.T., et al. Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence. Infect. Immun. 2000;68(8): 4673–80. DOI: https://doi.org/10.1128/IAI.68.8.4673-4680.2000
  17. DeShazer D., Brett P.J., Woods D.E. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol. Microbiol. 1998;30(5):1081–100. DOI: https://doi.org/10.1046/j.1365-2958.1998.01139.x
  18. Ugalde J.E., Czibener C., Feldman M.F., Ugalde R.A. Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication. Infect. Immun. 2000;68(10):5716–23. DOI: https://doi.org/10.1128/IAI.68.10.5716-5723.2000
  19. Winn A.M., Wilkinson S.G. Structures of the O4 and O18 antigens of Stenotrophomonas maltophilia: a case of enantiomeric repeating units. Carbohydr. Res. 2001;330(2):215–21. DOI: https://doi.org/10.1016/S0008-6215(00)00287-1
  20. Flores-Treviño S., Bocanegra-Ibarias P., Camacho-Ortiz A., et al. Stenotrophomonas maltophilia biofilm: its role in infectious diseases. Expert. Rev. Anti Infect. Ther. 2019;17(11):877–93. DOI: https://doi.org/10.1080/14787210.2019.1685875
  21. Huang T.P., Somers E.B., Wong A.C.L. Differential biofilm formation and motility associated with lipopolysaccharide/exopolysaccharide-coupled biosynthetic genes in Stenotrophomonas maltophilia. J. Bacteriol. 2006;188(8):3116–20. DOI: https://doi.org/10.1128/JB.188.8.3116-3120.2006
  22. de Oliveira-Garcia D., Dall’Agnol M., Rosales M., et al. Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia. Emerg. Infect. Dis. 2002;8(9):918–23. DOI: https://doi.org/10.3201/eid0809.010535
  23. Zgair A.K., Chhibber S. Adhesion of Stenotrophomonas maltophilia to mouse tracheal mucus is mediated through flagella. J. Med. Microbiol. 2011;60(7):1032–7. DOI: https://doi.org/10.1099/jmm.0.026377-0
  24. Zgair A.K., Chhibber S. Stenotrophomonas maltophilia flagellin restricts bacterial colonization in BALB/c mouse lung in vivo. FEMS Immunol. Med. Microbiol. 2012;66(2):191–200. DOI: https://doi.org/10.1111/j.1574-695X.2012.00999.x
  25. Pompilio A., Crocetta V., Di Bonaventura G. Stenotrophomonas maltophilia mutant lacking flagella remains virulent in DBA/2N mice but is less efficient in stimulating TNF-α expression. FEMS Microbiol. Lett. 2018;365(19). DOI: https://doi.org/10.1093/femsle/fny205
  26. Mahenthiralingam E., Campbell M.E., Speert D.P. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 1994;62(2):596–605. DOI: https://doi.org/10.1128/iai.62.2.596-605.1994
  27. Pompilio A., Crocetta V., Confalone P., et al. Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. BMC Microbiol. 2010;10(1):102. DOI: https://doi.org/10.1186/1471-2180-10-102
  28. Ross P., Weinhouse H., Aloni Y., et al. Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid. Nature. 1987325(6101):279–81. DOI: https://doi.org/10.1038/325279a0
  29. Cheng S.T., Wang F.F., Qian W. Cyclic-di-GMP binds to histidine kinase RavS to control RavS-RavR phosphotransfer and regulates the bacterial lifestyle transition between virulence and swimming. PLOS Pathog. 2019;15(8):e1007952. DOI: https://doi.org/10.1371/journal.ppat.1007952
  30. Chan C., Paul R., Samoray D., et al. Structural basis of activity and allosteric control of diguanylate cyclase. Proc. Natl. Acad. Sci. USA. 2004;101(49):17084–9. DOI: https://doi.org/10.1073/pnas.0406134101
  31. Christen M., Christen B., Folcher M., et al. Identification and characterization of a cyclic di-GMP-specific phosphodiesterase and its allosteric control by GTP. J. Biol. Chem. 2005;280(35):30829–37. DOI: https://doi.org/10.1074/jbc.M504429200
  32. Caly D., Bellini D., Walsh M., et al. Targeting cyclic di-GMP signalling: a strategy to control biofilm formation? Curr. Pharm. Des. 2014;21(1):12–24. DOI: https://doi.org/10.2174/1381612820666140905124701
  33. Arora S.K., Ritchings B.W., Almira E.C., et al. A transcriptional activator, FleQ, regulates mucin adhesion and flagellar gene expression in Pseudomonas aeruginosa in a cascade manner. J. Bacteriol. 1997;179(17):5574–81. DOI: https://doi.org/10.1128/jb.179.17.5574-5581.1997
  34. Hickman J.W., Harwood C.S. Identification of FleQ from Pseudomonas aeruginosa as a c-di-GMP-responsive transcription factor. Mol. Microbiol. 2008;69(2):376–89. DOI: https://doi.org/10.1111/j.1365-2958.2008.06281.x
  35. Klose K.E., Mekalanos J.J. Distinct roles of an alternative sigma factor during both free‐swimming and colonizing phases of the Vibrio cholerae pathogenic cycle. Mol. Microbiol. 1998;28(3):501–20. DOI: https://doi.org/10.1046/j.1365-2958.1998.00809.x
  36. Stewart B.J., McCarter L.L. Vibrio parahaemolyticus FlaJ, a homologue of FliS, is required for production of a flagellin. Mol. Microbiol. 1996;20(1):137–49. DOI: https://doi.org/10.1111/j.1365-2958.1996.tb02496.x
  37. Yang J.G., Shih M.S., Kuo W.T., et al. Crystallization of the N-terminal regulatory domain of the enhancer-binding protein FleQ from Stenotrophomonas maltophilia. Acta Crystallogr. F. Struct. Biol. Commun. 2014;70(Pt. 3):326–30. DOI: https://doi.org/10.1107/S2053230X14001514
  38. Liu W., Tian X.Q., Wei J.W., et al. BsmR degrades c-di-GMP to modulate biofilm formation of nosocomial pathogen Stenotrophomonas maltophilia. Sci. Rep. 2017;7(1):4665. DOI: https://doi.org/10.1038/s41598-017-04763-w
  39. Kang X.M., Wang F.F., Zhang H., et al. Genome-wide identification of genes necessary for biofilm formation by nosocomial pathogen Stenotrophomonas maltophilia reveals that orphan response regulator FsnR is a critical modulator. Appl. Environ. Microbiol. 2015;81(4):1200–9. DOI: https://doi.org/10.1128/AEM.03408-14
  40. Zheng L., Wang F.F., Ren B.Z., et al. Systematic mutational analysis of histidine kinase genes in the nosocomial pathogen Stenotrophomonas maltophilia identifies BfmAK system control of biofilm development. Appl. Environ. Microbiol. 2016;82(8):2444–56. DOI: https://doi.org/10.1128/AEM.03951-15
  41. Zhang X., Wang Y., Wu Y., et al. Dual regulatory role exerted by cyclic dimeric GMP To control FsnR-mediated bacterial swimming. MBio. 2022;13(5):e0141422. DOI: https://doi.org/10.1128/mbio.01414-22
  42. de Oliveira-Garcia D., Dall’Agnol M., Rosales M., et al. Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces. Cell Microbiol. 2003;5(9):625–36. DOI: https://doi.org/10.1046/j.1462-5822.2003.00306.x
  43. Zgair A.K., Al-Adressi A.M.H. Stenotrophomonas maltophilia fimbrin stimulates mouse bladder innate immune response. Eur. J. Clin. Microbiol. Infect. Dis. 2013;32(1):139–46. DOI: https://doi.org/10.1007/s10096-012-1729-0
  44. Nicoletti M., Iacobino A., Prosseda G., et al. Stenotrophomonas maltophilia strains from cystic fibrosis patients: Genomic variability and molecular characterization of some virulence determinants. Int. J. Med. Microbiol. 2011;301(1):34–43. DOI: https://doi.org/10.1016/j.ijmm.2010.07.003
  45. Crossman L.C., Gould V.C., Dow J.M., et al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 2008;9(4):R74. DOI: https://doi.org/10.1186/gb-2008-9-4-r74
  46. Giltner C.L., Nguyen Y., Burrows L.L. Type IV pilin proteins: versatile molecular modules. Microbiol. Mol. Biol. Rev. 2012;76(4):740–72. DOI: https://doi.org/10.1128/MMBR.00035-12
  47. Travassos L.H., Pinheiro M.N., Coelho F.S., et al. Phenotypic properties, drug susceptibility and genetic relatedness of Stenotrophomonas maltophilia clinical strains from seven hospitals in Rio de Janeiro, Brazil. J. Appl. Microbiol. 2004;96(5):1143–50. DOI: https://doi.org/10.1111/j.1365-2672.2004.02248.x
  48. Trifonova A., Strateva T. Stenotrophomonas maltophilia — a low-grade pathogen with numerous virulence factors. Infect. Dis. 2019;51(3):168–78. DOI: https://doi.org/10.1080/23744235.2018.1531145
  49. Adamek M., Linke B., Schwartz T. Virulence genes in clinical and environmental Stenotrophomas maltophilia isolates: a genome sequencing and gene expression approach. Microb. Pathog. 2014;67-68:20–30. DOI: https://doi.org/10.1016/j.micpath.2014.02.001
  50. Alavi P., Starcher M.R., Thallinger G.G., et al. Stenotrophomonas comparative genomics reveals genes and functions that differentiate beneficial and pathogenic bacteria. BMC Genomics. 2014;15(1):482. DOI: https://doi.org/10.1186/1471-2164-15-482
  51. DuMont A.L., Karaba S.M., Cianciotto N.P. Type II secretion-dependent degradative and cytotoxic activities mediated by Stenotrophomonas maltophilia serine proteases StmPr1 and StmPr2. Infect. Immun. 2015;83(10):3825–37. DOI: https://doi.org/10.1128/IAI.00672-15
  52. DuMont A.L., Cianciotto N.P. Stenotrophomonas maltophilia serine protease StmPr1 induces matrilysis, anoikis, and protease-activated receptor 2 Activation in human lung epithelial cells. Infect. Immun. 2017;85(12):e00544-17. DOI: https://doi.org/10.1128/IAI.00544-17
  53. Windhorst S., Frank E., Georgieva D.N., et al. The major extracellular protease of the nosocomial pathogen Stenotrophomonas maltophilia. J. Biol. Chem. 2002;277(13):11042–9. DOI: https://doi.org/10.1074/jbc.M109525200
  54. Ribitsch D., Heumann S., Karl W., et al. Extracellular serine proteases from Stenotrophomonas maltophilia: screening, isolation and heterologous expression in E. coli. J. Biotechnol. 2012; 157(1):140–7. DOI: https://doi.org/10.1016/j.jbiotec.2011.09.025
  55. Nas M.Y., Gabell J., Cianciotto N.P. Effectors of the Stenotrophomonas maltophilia Type IV secretion system mediate killing of clinical isolates of Pseudomonas aeruginosa. MBio. 2021; 12(3):e0150221. DOI: https://doi.org/10.1128/mBio.01502-21
  56. Nas M.Y., White R.C., DuMont A.L., et al. Stenotrophomonas maltophilia encodes a VirB/VirD4 type IV secretion system that modulates apoptosis in human cells and promotes competition against heterologous bacteria, including Pseudomonas aeruginosa. Infect. Immun. 2019;87(9). DOI: https://doi.org/10.1128/IAI.00457-19
  57. Ramos-Hegazy L., Chakravarty S., Anderson G.G. Phosphoglycerate mutase affects Stenotrophomonas maltophilia attachment to biotic and abiotic surfaces. Microbes Infect. 2020;22(1): 60–4. DOI: https://doi.org/10.1016/j.micinf.2019.08.001
  58. Di Bonaventura G., Picciani C., Lupetti V., Pompilio A. Comparative proteomic analysis of protein patterns of Stenotrophomonas maltophilia in biofilm and planktonic lifestyles. Microorganisms. 2023;11(2):442. DOI: https://doi.org/10.3390/microorganisms11020442
  59. Pompilio A., Savini V., Fiscarelli E., et al. Clonal diversity, biofilm formation, and antimicrobial resistance among Stenotrophomonas maltophilia strains from cystic fibrosis and non-cystic fibrosis patients. Antibiotics (Basel). 2020;9(1):15. DOI: https://doi.org/10.3390/antibiotics9010015
  60. Alio I., Gudzuhn M., Pérez García P., et al. Phenotypic and transcriptomic analyses of seven clinical Stenotrophomonas maltophilia isolates identify a small set of shared and commonly regulated genes involved in the biofilm lifestyle. Appl. Environ. Microbiol. 2020;86(24):e02038-20. DOI: https://doi.org/10.1128/AEM.02038-20
  61. Lin Y.T., Huang Y.W., Liou R.S., et al. MacABCsm, an ABC-type tripartite efflux pump of Stenotrophomonas maltophilia involved in drug resistance, oxidative and envelope stress tolerances and biofilm formation. J. Antimicrob. Chemother. 2014;69(12):3221–6. DOI: https://doi.org/10.1093/jac/dku317
  62. Huang Y.W., Hu R.M., Chu F.Y., et al. Characterization of a major facilitator superfamily (MFS) tripartite efflux pump EmrCABsm from Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 2013;68(11):2498–505. DOI: https://doi.org/10.1093/jac/dkt250
  63. Hu R.M., Liao S.T., Huang C.C., et al. An inducible fusaric acid tripartite efflux pump contributes to the fusaric acid resistance in Stenotrophomonas maltophilia. PLoS One. 2012;7(12):e51053. DOI: https://doi.org/10.1371/journal.pone.0051053
  64. Gil-Gil T., Martínez J.L., Blanco P. Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge. Expert. Rev. Anti Infect. Ther. 2020;18(4):335–47. DOI: https://doi.org/10.1080/14787210.2020.1730178
  65. Wu C.J., Chen Y., Li L.H., et al. Efflux systems in iron homeostasis of Stenotrophomonas maltophilia. Microbiol. Spectr. 2022;10(3):e0244821. DOI: https://doi.org/10.1128/spectrum.02448-21
  66. Hirakata Y., Srikumar R., Poole K., et al. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J. Exp. Med. 2002;196(1):109–18. DOI: https://doi.org/10.1084/jem.20020005
  67. Brunson D.N., Maldosevic E., Velez A., et al. Porin loss in Klebsiella pneumoniae clinical isolates impacts production of virulence factors and survival within macrophages. Int. J. Med. Microbiol. 2019;309(3-4):213–24. DOI: https://doi.org/10.1016/j.ijmm.2019.04.001
  68. Jurado R.L. Iron, infections, and anemia of inflammation. Clin. Infect. Dis. 1997;25(4):888–95. DOI: https://doi.org/10.1086/515549
  69. Kalidasan V., Joseph N., Kumar S., et al. Iron and virulence in Stenotrophomonas maltophilia: all we know so far. Front. Cell Infect. Microbiol. 2018;8:401. DOI: https://doi.org/10.3389/fcimb.2018.00401
  70. Nairz M., Schroll A., Sonnweber T., Weiss G. The struggle for iron — a metal at the host-pathogen interface. Cell Microbiol. 2010;12(12):1691–702. DOI: https://doi.org/10.1111/j.1462-5822.2010.01529.x
  71. García C.A., Alcaraz E.S., Franco M.A., Passerini de Rossi B.N. Iron is a signal for Stenotrophomonas maltophilia biofilm formation, oxidative stress response, OMPs expression, and virulence. Front. Microbiol. 2015;6:926. DOI: https://doi.org/10.3389/fmicb.2015.00926
  72. Huang T.P., Lee Wong A.C. A cyclic AMP receptor protein-regulated cell-cell communication system mediates expression of a FecA homologue in Stenotrophomonas maltophilia. Appl. Environ. Microbiol. 2007;73(15):5034–40. DOI: https://doi.org/10.1128/AEM.00366-07
  73. Papenfort K., Bassler B.L. Quorum sensing signal-response systems in Gram-negative bacteria. Nat. Rev. Microbiol. 2016;14(9):576–88. DOI: https://doi.org/10.1038/nrmicro.2016.89
  74. Huedo P., Yero D., Martínez-Servat S., et al. Two different rpf clusters distributed among a population of Stenotrophomonas maltophilia clinical strains display differential diffusible signal factor production and virulence regulation. J. Bacteriol. 2014; 196(13):2431–42. DOI: https://doi.org/10.1128/JB.01540-14
  75. Huedo P., Kumar V.P., Horgan C., et al. Sulfonamide-based diffusible signal factor analogs interfere with quorum sensing in Stenotrophomonas maltophilia and Burkholderia cepacia. Future Med. Chem. 2019;11(13):1565–82. DOI: https://doi.org/10.4155/fmc-2019-0015
  76. Huedo P., Yero D., Martinez-Servat S., et al. Decoding the genetic and functional diversity of the DSF quorum-sensing system in Stenotrophomonas maltophilia. Front. Microbiol. 2015;6:761. DOI: https://doi.org/10.3389/fmicb.2015.00761
  77. Yero D., Huedo P., Conchillo-Solé O., et al. Genetic variants of the DSF quorum sensing system in Stenotrophomonas maltophilia influence virulence and resistance phenotypes among genotypically diverse clinical isolates. Front. Microbiol. 2020;11:1160. DOI: https://doi.org/10.3389/fmicb.2020.01160
  78. Martínez P., Huedo P., Martinez-Servat S., et al. Stenotrophomonas maltophilia responds to exogenous AHL signals through the LuxR solo SmoR (Smlt1839). Front. Cell Infect. Microbiol. 2015;5:41. DOI: https://doi.org/10.3389/fcimb.2015.00041
  79. McCarthy Y., Dow J.M., Ryan R.P. The Ax21 protein is a cell-cell signal that regulates virulence in the nosocomial pathogen Stenotrophomonas maltophilia. J. Bacteriol. 2011;193(22):6375–8. DOI: https://doi.org/10.1128/JB.05949-11
  80. Devos S., Van Oudenhove L., Stremersch S., et al. The effect of imipenem and diffusible signaling factors on the secretion of outer membrane vesicles and associated Ax21 proteins in Stenotrophomonas maltophilia. Front. Microbiol. 2015;6:298. DOI: https://doi.org/10.3389/fmicb.2015.00298
  81. Park H.J., Lee S.W., Han S.W. Proteomic and functional analyses of a novel porin-like protein in Xanthomonas oryzae pv. oryzae. J. Microbiol. 2014;52(12):1030–5. DOI: https://doi.org/10.1007/s12275-014-4442-0.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2023 Mikhailovich V.M., Geydarov R.N., Bocharova J.A., Chebotar I.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies